Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The NUDT15 R139C variant causes thiopurine-induced leukocytopenia through a different mechanism than previously thought in Japanese patients with inflammatory bowel disease.

Effective treatment for UFT overdose includes antibiotics and G-CSF, with bone marrow biopsy and transfusion as backup options.

Dutasteride effectively treats benign prostatic hyperplasia but isn't approved for preventing prostate cancer.

Topical finasteride may help treat facial hirsutism in women.

New compounds were developed that promote hair growth in mice.

Phenytoin, a medication, can cause hair loss and trigger a condition similar to lupus.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Non-daily Dutasteride is more cost-effective and has lower cancer incidence than daily treatment.

Flutamide worked better than finasteride for reducing excessive hair growth in women, but had more side effects.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

New compounds with carborane showed anti-androgen effects similar to flutamide.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

A woman with a skin disorder was found to have hepatitis C, which may be linked, and was safely treated with methotrexate.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Dutasteride is approved to help manage prostate enlargement.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

MK-5108 is safe and shows potential against tumors, especially alone.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

Estradiol and castration reduced prostate cancer development in rats when applied at early stages, but were ineffective after cancer was established.

The use of Diane-35 and its generics significantly decreased in the Netherlands.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Finasteride and flutamide both reduce hair growth, but finasteride has fewer side effects.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Bicalutamide mesotherapy improved hair density in women with hair loss and was well received.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

Mycophenolate mofetil is safer and more effective than cyclophosphamide for treating lupus nephritis.